secwatch.observer — SEC 8-K summary
======================================

Issuer:     VACCINEX, INC. (VCNX)
CIK:        0001205922
Form:       8-K
Filed at:   2025-03-07T23:59:59+00:00
Accession:  0001193125-25-049988
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaccinex voluntarily delists from Nasdaq; Form 25 filing expected March 17, 2025
--------------------------------------------------------------------------------

- Nasdaq trading suspended since December 18, 2024 following a hearing panel determination to delist.
- Company notified Nasdaq on March 7, 2025 of its intention to delist; filing Form 25 on or about March 17.
- Stock will continue to trade on OTC Pink under symbol VCNX.
- Vaccinex plans to continue development of pepinemab in Alzheimer's and cancer via partnerships and grants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1205922/000119312525049988/0001193125-25-049988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1205922/000119312525049988/d811414d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-049988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer